CSTONE PHARMA-B 02616
5.0902.86%( -0.150 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
CSTONE PHARMA-B (02616) Insider Trading - Director Trades and Holdings - cibo
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| Li Wei | 20.83K | -- | Derivatives exercised against | 2.25M | 0.14% | ||
| 胡正国Non-Executive Director | 20.83K | -- | Derivatives exercised against | 3.72M | 0.23% | ||
| Yang Jianxin | 63.00K | -- | Derivatives exercised against | 84.78M | 5.31% | ||
| Yang Jianxin | 6.88K | -- | Derivatives exercised against | 84.78M | 5.31% | ||
| Yang Jianxin | +291.50K | 5.63 | Bought | 84.78M | 5.31% | ||
| Yang Jianxin | +72.00K | 5.42 | Bought | 84.49M | 5.29% | ||
| Yang Jianxin | +132.50K | 5.24 | Bought | 84.42M | 5.29% | ||
| Li Wei | 41.67K | -- | Derivatives exercised against | 2.25M | 0.14% | ||
| 胡正国Non-Executive Director | 41.67K | -- | Derivatives exercised against | 3.72M | 0.23% | ||
| Yang Jianxin | 208.50K | -- | Derivatives exercised against | 84.28M | 5.28% | ||
| Yang Jianxin | 63.00K | -- | Derivatives exercised against | 84.28M | 5.27% | ||
| 胡正国Non-Executive Director | 20.83K | -- | Derivatives exercised against | 3.72M | 0.23% | ||
| Li Wei | 20.83K | -- | Derivatives exercised against | 2.25M | 0.14% | ||
| Yang Jianxin | +331.00K | 4.64 | Bought | 84.28M | 5.27% | ||
| Yang Jianxin | 448.88K | -- | Derivatives exercised against | 83.95M | 5.24% | ||
| 胡正国Non-Executive Director | 62.50K | -- | Derivatives exercised against | 3.72M | 0.23% | ||
| Li Wei | 62.50K | -- | Derivatives exercised against | 2.25M | 0.14% | ||
| Yang Jianxin | 11.27M | -- | Derivatives acquired | 83.95M | 5.24% | ||
| Li Wei | +100.00K | 4.56 | Bought | 2.25M | 0.14% | ||
| 胡正国Non-Executive Director | +150.00K | 4.66 | Bought | 3.72M | 0.23% | ||
| Yang Jianxin | +56.50K | 4.66 | Bought | 72.74M | 4.54% | ||
| Yang Jianxin | +200.00K | 4.57 | Bought | 72.68M | 4.54% | ||
| Li Wei | +100.00K | 4.44 | Bought | 2.15M | 0.13% | ||
| 胡正国Non-Executive Director | +100.00K | 4.47 | Bought | 3.57M | 0.22% | ||
| Li Wei | +50.00K | 4.40 | Bought | 2.05M | 0.13% | ||
| Yang Jianxin | +145.00K | 4.26 | Bought | 72.48M | 4.53% | ||
| Yang Jianxin | +200.00K | 4.25 | Bought | 72.34M | 4.52% | ||
| Kenneth Walton Hitchner IIINon-Executive Director | +400.00K | 4.48 | Bought | 2.51M | 0.16% |
Changes in interests filed with HKEX by directors and chief executives. The bought/sold totals count long-position purchases and sales only; option exercises, grants and other events are left out.
| Shareholder | |||
|---|---|---|---|
| Jiang Frank Ningjun | 7.05% | 83.80M | |
| Yang Jianxin | 5.31% | 84.78M | |
| 童小幪 | 1.33% | 13.08M | |
| 胡正国Non-Executive Director | 0.24% | 3.47M | |
| 胡正国Non-Executive Director | 0.23% | 3.72M | |
| Kenneth Walton Hitchner IIINon-Executive Director | 0.16% | 2.51M | |
| Li Wei | 0.14% | 2.25M | |
| Kenneth Walton Hitchner IIINon-Executive Director | 0.14% | 2.11M | |
| 谢芳Independent Non-Executive Director | <0.01% | 8.50K |
From the HKEXnews Disclosure of Interests complete list of directors: each director's long position after their latest filing.
This page shows share dealings filed by CSTONE PHARMA-B (02616) directors and chief executives over the past year (date, shares, price, type and holding afterwards) with bought and sold totals, and each director's current holding. Data comes from the HKEXnews Disclosure of Interests (DI) section.
